Literature DB >> 34357570

Direct oral anticoagulants and chronic kidney disease: it is time to be brave.

Marco Valerio Mariani1, Luca Di Lullo2, Carlo Lavalle3.   

Abstract

Entities:  

Year:  2021        PMID： 34357570     DOI： 10.1007/s40620-021-01137-4

Source DB:  PubMed          Journal:  J Nephrol        ISSN： 1121-8428            Impact factor:   3.902


× No keyword cloud information.
  1 in total

1.  Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial.

Authors:  An S De Vriese; Rogier Caluwé; Hans Van Der Meersch; Koen De Boeck; Dirk De Bacquer
Journal:  J Am Soc Nephrol       Date:  2021-03-22       Impact factor: 14.978
  1 in total
  1 in total

1.  Five Years of Direct Oral Anticoagulants Use in Italy: Adverse Drug Reactions from the Italian National Pharmacovigilance Network.

Authors:  Carlo Lavalle; Marco Valerio Mariani; Agostino Piro; Michele Magnocavallo; Giampaolo Vetta; Sara Trivigno; Giovanni Battista Forleo; Domenico Giovanni Della Rocca; Massimo Uguccioni; Vincenzo Russo; Francesco Summaria; Luca Di Lullo
Journal:  J Clin Med       Date:  2022-06-04       Impact factor: 4.964
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.